# A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder

> **NCT00106860** · PHASE3 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 158 (—)

## Conditions studied

- Anxiety Disorder

## Interventions

- **DRUG:** a benzodiazepine drug

## Key facts

- **NCT ID:** NCT00106860
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 158 (—)
- **Last updated:** 2008-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00106860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00106860, "A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00106860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*